Systems pharmacology augments drug safety surveillance

Small molecule drugs are the foundation of modern medical practice yet their use is limited by the onset of unexpected and severe adverse events (AEs). Regulatory agencies rely on post-marketing surveillance to monitor safety once drugs are approved for clinical use. Despite advances in pharmacovigi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorberbaum, Tal, Nasir, Mavra, Keiser, Michael J., Vilar, Santiago, Hripcsak, George, Tatonetti, Nicholas P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325423/
https://www.ncbi.nlm.nih.gov/pubmed/25670520
http://dx.doi.org/10.1002/cpt.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325423/
https://www.ncbi.nlm.nih.gov/pubmed/25670520
http://dx.doi.org/10.1002/cpt.2

Ejemplares similares